Global Drug Abuse Treatment Market Growth (Status and Outlook) 2024-2030

2024

Global Drug Abuse Treatment Market Growth (Status and Outlook) 2024-2030

Name: Global Drug Abuse Treatment Market Growth (Status and Outlook) 2024-2030
Creator: Bonafide Research
License: https://www.bonafideresearch.com/license_information

Drug Abuse Treatment, valued at US$ 17.77 billion in 2023, is forecasted to reach US$ 28.26 billion by 2030, with a 6.8% CAGR attributed to rising downstream demand.

Bonafide Trust
04-01-2024
Pages : 115
Figures : 77
Tables : 101
Region : Global
Category : Lifescience
Healthcare

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

According to Publisher’s latest study, the global Drug Abuse Treatment market was valued at US$ 17770 million in 2023. With the growing demand in the downstream market, Drug Abuse Treatment is forecast to a readjusted size of US$ 28260 million by 2030 with a CAGR of 6.8% during the review period.

Market Overview

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The research report highlights the growth potential of the global Drug Abuse Treatment market. Drug Abuse Treatments are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Abuse Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Abuse Treatment market.

Drug Abuse can be defined as habitual, dependence of an individual on any drugs, which turns into an addiction. Opioids, alcohol, tobacco and cigarettes are some of the common, drugs that have been misused leading to drug addictions. In the recent past, many products have been launched in the market for the treatment and management of drug abuse. Some commonly used drugs for the treatment of drug abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Key Features:

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Research Consultant

The report on the Drug Abuse Treatment market reflects various aspects and provides valuable insights into the industry.

Market Drivers and Challenges: Growing Need for Interventions Based on Evidence: Comprehending the effectiveness of evidence-based treatment approaches like CBT, MAT, and motivational interviewing is a key factor in the adoption of comprehensive treatment programs that cater to the multifaceted needs of patients with substance use disorders.

Funding and Initiatives by the Government: The expansion of treatment services for substance misuse, the enhancement of healthcare facilities, and the resolution of inequalities in treatment accessibility and quality are all factors that support the growth and sustainability of the market. These factors include government initiatives, policy reforms, and budget allocations.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Combining Services for Behavioral Health: Reducing stigma and enhancing access to care are achieved through the integration of behavioural health services into community health centres, correctional facilities, and primary care settings. This allows for early intervention, screening, and referral to substance misuse treatment programs.

Challenges- Discrimination and Stigma: People with drug misuse problems are discouraged from seeking treatment due to societal hurdles, discrimination, and stigma. This results in delayed intervention, underutilization of services, and a higher risk of unfavourable health consequences.

Treatment Disparities and Access Barriers: In underserved regions, rural locations, and low-income people, in particular, disparities in treatment availability, quality, and access exacerbate health disparities and reduce the efficacy of intervention initiatives.

Dual Diagnosis and Co-occurring Disorders: People with substance use disorders are more likely to have co-occurring mental health problems, trauma, and chronic medical issues. This makes treatment results more difficult and calls for integrated, multidisciplinary approaches to care.

Market Forecasts and Future Outlook: Personalized Treatment Approaches: Precision medicine, pharmacogenomics, and biomarker research advances have made it possible to customize treatment plans based on the unique characteristics of each patient, their genetic makeup, and their reaction to treatment. This has improved treatment results and decreased the likelihood of relapse.

The growth of digital therapies, virtual care platforms, and telehealth services makes it easier to do remote assessments, track patient progress, and administer evidence-based treatments. This increases treatment accessibility, especially for underprivileged and rural populations.

Community-Based Interventions: A growing number of people with substance use disorders are being empowered to seek treatment, lessen harm, and participate in recovery-focused activities in their communities through the use of community-based interventions, peer support groups, and harm reduction initiatives.

Opportunities: Expansion of Treatment Infrastructure: To address the rising demand for drug abuse treatment services, there are opportunities for market expansion and capacity-building by funding the construction of outpatient clinics, residential rehabilitation centres, and treatment infrastructure in underserved areas and low-resource settings.

Creative Payment Schemes: Collaboration between payers, providers, and stakeholders is facilitated by investigating novel payment models, reimbursement systems, and value-based care initiatives that reward treatment outcomes, care quality, and patient participation. These efforts aim to optimize treatment delivery and allocation of resources.

Integration of Peer Support Services: A comprehensive approach to drug abuse treatment and recovery is fostered by incorporating peer support services, recovery coaching, and community-based organizations into the continuum of care. This improves treatment engagement, social support, and long-term recovery outcomes.

Market Segmentation:

Drug Abuse Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
1. Segmentation by type
• Opioid Addiction
• Tobacco/Nicotine Addiction
• Alcohol Dependence
2. Segmentation by application
• Hospital & Clinics
• Residential (non-hospital)

Regional Insights: The opioid crisis, the rise in methamphetamine use, the need for medication-assisted therapy (MAT) and harm reduction programs, and the United States have made America the largest market for drug misuse treatment services. With its variety of treatment modalities, harm reduction tactics, and publicly funded healthcare systems that offer access to a full range of drug abuse treatment services, such as detoxification, rehabilitation, and opioid substitution therapy, Europe represents a sizable market for drug abuse treatment. With growing drug abuse rates, shifting drug use patterns, and developing regulatory frameworks driving investments in treatment infrastructure, capacity-building, and prevention initiatives in nations like China, India, and Southeast Asia, the Asia-Pacific region is becoming a more important market for drug abuse treatment. North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is a follower, accounting for about 33% market share.
3. Americas
• United States
• Canada
• Mexico
• Brazil
4. APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
5. Europe
• Germany
• France
• UK
• Italy
• Russia
6. Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape- The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr Reddy's Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. The top 5 companies occupied about 14% market share. The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
• Indivior
• Pfizer
• Alkermes
• Novartis
• Mylan
• Cipla
• Glenmark
• Dr Reddy's Laboratories
• Teva Pharmaceutical
• PLIVA (Odyssey)

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Abuse Treatment Market Size 2019-2030
2.1.2 Drug Abuse Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug Abuse Treatment Segment by Type
2.2.1 Opioid Addiction
2.2.2 Tobacco/Nicotine Addiction
2.2.3 Alcohol Dependence
2.3 Drug Abuse Treatment Market Size by Type
2.3.1 Drug Abuse Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug Abuse Treatment Market Size Market Share by Type (2019-2024)
2.4 Drug Abuse Treatment Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Residential (non-hospital)
2.5 Drug Abuse Treatment Market Size by Application
2.5.1 Drug Abuse Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug Abuse Treatment Market Size Market Share by Application (2019-2024)
3 Drug Abuse Treatment Market Size by Player
3.1 Drug Abuse Treatment Market Size Market Share by Players
3.1.1 Global Drug Abuse Treatment Revenue by Players (2019-2024)
3.1.2 Global Drug Abuse Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Drug Abuse Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Abuse Treatment by Regions
4.1 Drug Abuse Treatment Market Size by Regions (2019-2024)
4.2 Americas Drug Abuse Treatment Market Size Growth (2019-2024)
4.3 APAC Drug Abuse Treatment Market Size Growth (2019-2024)
4.4 Europe Drug Abuse Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Drug Abuse Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Drug Abuse Treatment Market Size by Country (2019-2024)
5.2 Americas Drug Abuse Treatment Market Size by Type (2019-2024)
5.3 Americas Drug Abuse Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Abuse Treatment Market Size by Region (2019-2024)
6.2 APAC Drug Abuse Treatment Market Size by Type (2019-2024)
6.3 APAC Drug Abuse Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Abuse Treatment by Country (2019-2024)
7.2 Europe Drug Abuse Treatment Market Size by Type (2019-2024)
7.3 Europe Drug Abuse Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Abuse Treatment by Region (2019-2024)
8.2 Middle East & Africa Drug Abuse Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Drug Abuse Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Abuse Treatment Market Forecast
10.1 Global Drug Abuse Treatment Forecast by Regions (2025-2030)
10.1.1 Global Drug Abuse Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Drug Abuse Treatment Forecast
10.1.3 APAC Drug Abuse Treatment Forecast
10.1.4 Europe Drug Abuse Treatment Forecast
10.1.5 Middle East & Africa Drug Abuse Treatment Forecast
10.2 Americas Drug Abuse Treatment Forecast by Country (2025-2030)
10.2.1 United States Drug Abuse Treatment Market Forecast
10.2.2 Canada Drug Abuse Treatment Market Forecast
10.2.3 Mexico Drug Abuse Treatment Market Forecast
10.2.4 Brazil Drug Abuse Treatment Market Forecast
10.3 APAC Drug Abuse Treatment Forecast by Region (2025-2030)
10.3.1 China Drug Abuse Treatment Market Forecast
10.3.2 Japan Drug Abuse Treatment Market Forecast
10.3.3 Korea Drug Abuse Treatment Market Forecast
10.3.4 Southeast Asia Drug Abuse Treatment Market Forecast
10.3.5 India Drug Abuse Treatment Market Forecast
10.3.6 Australia Drug Abuse Treatment Market Forecast
10.4 Europe Drug Abuse Treatment Forecast by Country (2025-2030)
10.4.1 Germany Drug Abuse Treatment Market Forecast
10.4.2 France Drug Abuse Treatment Market Forecast
10.4.3 UK Drug Abuse Treatment Market Forecast
10.4.4 Italy Drug Abuse Treatment Market Forecast
10.4.5 Russia Drug Abuse Treatment Market Forecast
10.5 Middle East & Africa Drug Abuse Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Drug Abuse Treatment Market Forecast
10.5.2 South Africa Drug Abuse Treatment Market Forecast
10.5.3 Israel Drug Abuse Treatment Market Forecast
10.5.4 Turkey Drug Abuse Treatment Market Forecast
10.5.5 GCC Countries Drug Abuse Treatment Market Forecast
10.6 Global Drug Abuse Treatment Forecast by Type (2025-2030)
10.7 Global Drug Abuse Treatment Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Indivior
11.1.1 Indivior Company Information
11.1.2 Indivior Drug Abuse Treatment Product Offered
11.1.3 Indivior Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Indivior Main Business Overview
11.1.5 Indivior Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Drug Abuse Treatment Product Offered
11.2.3 Pfizer Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Alkermes
11.3.1 Alkermes Company Information
11.3.2 Alkermes Drug Abuse Treatment Product Offered
11.3.3 Alkermes Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Alkermes Main Business Overview
11.3.5 Alkermes Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Drug Abuse Treatment Product Offered
11.4.3 Novartis Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Drug Abuse Treatment Product Offered
11.5.3 Mylan Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Mylan Main Business Overview
11.5.5 Mylan Latest Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Drug Abuse Treatment Product Offered
11.6.3 Cipla Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Cipla Main Business Overview
11.6.5 Cipla Latest Developments
11.7 Glenmark
11.7.1 Glenmark Company Information
11.7.2 Glenmark Drug Abuse Treatment Product Offered
11.7.3 Glenmark Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Glenmark Main Business Overview
11.7.5 Glenmark Latest Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Information
11.8.2 Dr. Reddy's Laboratories Drug Abuse Treatment Product Offered
11.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Dr. Reddy's Laboratories Main Business Overview
11.8.5 Dr. Reddy's Laboratories Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Drug Abuse Treatment Product Offered
11.9.3 Teva Pharmaceutical Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
11.10 PLIVA (Odyssey)
11.10.1 PLIVA (Odyssey) Company Information
11.10.2 PLIVA (Odyssey) Drug Abuse Treatment Product Offered
11.10.3 PLIVA (Odyssey) Drug Abuse Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 PLIVA (Odyssey) Main Business Overview
11.10.5 PLIVA (Odyssey) Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Drug Abuse Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Opioid Addiction
Table 3. Major Players of Tobacco/Nicotine Addiction
Table 4. Major Players of Alcohol Dependence
Table 5. Drug Abuse Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Drug Abuse Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Drug Abuse Treatment Market Size Market Share by Type (2019-2024)
Table 8. Drug Abuse Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Drug Abuse Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Drug Abuse Treatment Market Size Market Share by Application (2019-2024)
Table 11. Global Drug Abuse Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Drug Abuse Treatment Revenue Market Share by Player (2019-2024)
Table 13. Drug Abuse Treatment Key Players Head office and Products Offered
Table 14. Drug Abuse Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drug Abuse Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Drug Abuse Treatment Market Size Market Share by Regions (2019-2024)
Table 19. Global Drug Abuse Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Drug Abuse Treatment Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Drug Abuse Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Drug Abuse Treatment Market Size Market Share by Country (2019-2024)
Table 23. Americas Drug Abuse Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Drug Abuse Treatment Market Size Market Share by Type (2019-2024)
Table 25. Americas Drug Abuse Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Drug Abuse Treatment Market Size Market Share by Application (2019-2024)
Table 27. APAC Drug Abuse Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Drug Abuse Treatment Market Size Market Share by Region (2019-2024)
Table 29. APAC Drug Abuse Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Drug Abuse Treatment Market Size Market Share by Type (2019-2024)
Table 31. APAC Drug Abuse Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Drug Abuse Treatment Market Size Market Share by Application (2019-2024)
Table 33. Europe Drug Abuse Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Drug Abuse Treatment Market Size Market Share by Country (2019-2024)
Table 35. Europe Drug Abuse Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Drug Abuse Treatment Market Size Market Share by Type (2019-2024)
Table 37. Europe Drug Abuse Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Drug Abuse Treatment Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Drug Abuse Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Drug Abuse Treatment Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Drug Abuse Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Drug Abuse Treatment Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Drug Abuse Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Drug Abuse Treatment Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Drug Abuse Treatment
Table 46. Key Market Challenges & Risks of Drug Abuse Treatment
Table 47. Key Industry Trends of Drug Abuse Treatment
Table 48. Global Drug Abuse Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Drug Abuse Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Drug Abuse Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Drug Abuse Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Indivior Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 53. Indivior Drug Abuse Treatment Product Offered
Table 54. Indivior Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Indivior Main Business
Table 56. Indivior Latest Developments
Table 57. Pfizer Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 58. Pfizer Drug Abuse Treatment Product Offered
Table 59. Pfizer Main Business
Table 60. Pfizer Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Pfizer Latest Developments
Table 62. Alkermes Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 63. Alkermes Drug Abuse Treatment Product Offered
Table 64. Alkermes Main Business
Table 65. Alkermes Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Alkermes Latest Developments
Table 67. Novartis Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 68. Novartis Drug Abuse Treatment Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Novartis Latest Developments
Table 72. Mylan Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 73. Mylan Drug Abuse Treatment Product Offered
Table 74. Mylan Main Business
Table 75. Mylan Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Mylan Latest Developments
Table 77. Cipla Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 78. Cipla Drug Abuse Treatment Product Offered
Table 79. Cipla Main Business
Table 80. Cipla Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Cipla Latest Developments
Table 82. Glenmark Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 83. Glenmark Drug Abuse Treatment Product Offered
Table 84. Glenmark Main Business
Table 85. Glenmark Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Glenmark Latest Developments
Table 87. Dr. Reddy's Laboratories Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 88. Dr. Reddy's Laboratories Drug Abuse Treatment Product Offered
Table 89. Dr. Reddy's Laboratories Main Business
Table 90. Dr. Reddy's Laboratories Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Dr. Reddy's Laboratories Latest Developments
Table 92. Teva Pharmaceutical Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 93. Teva Pharmaceutical Drug Abuse Treatment Product Offered
Table 94. Teva Pharmaceutical Main Business
Table 95. Teva Pharmaceutical Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Teva Pharmaceutical Latest Developments
Table 97. PLIVA (Odyssey) Details, Company Type, Drug Abuse Treatment Area Served and Its Competitors
Table 98. PLIVA (Odyssey) Drug Abuse Treatment Product Offered
Table 99. PLIVA (Odyssey) Main Business
Table 100. PLIVA (Odyssey) Drug Abuse Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. PLIVA (Odyssey) Latest Developments

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Anupriya Singh

Business Development Manager

Interested to schedule a FACE-TO-FACE meeting? Schedule a Call

Trusted Partners

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

Order Placed (26 January, 2025)
Notify To Team (26 January, 2025)
Report updation (27 January, 2025)
Report Quality Check (27 January, 2025)
Report Dispatch (28 January, 2025)

Email
Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Searching...

Global Drug Abuse Treatment Market Growth (Status and Outlook) 2024-2030

2024